Global Tumor Early Screening Products Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Early Screening Products Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Cervical Cancer
1.2.5 Oral Cancer
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tumor Early Screening Products Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 In-hospital Clinic
1.3.3 Medical Center
1.3.4 Community
1.3.5 Family
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tumor Early Screening Products Market Perspective (2017-2028)
2.2 Tumor Early Screening Products Growth Trends by Region
2.2.1 Tumor Early Screening Products Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tumor Early Screening Products Historic Market Size by Region (2017-2022)
2.2.3 Tumor Early Screening Products Forecasted Market Size by Region (2023-2028)
2.3 Tumor Early Screening Products Market Dynamics
2.3.1 Tumor Early Screening Products Industry Trends
2.3.2 Tumor Early Screening Products Market Drivers
2.3.3 Tumor Early Screening Products Market Challenges
2.3.4 Tumor Early Screening Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Early Screening Products Players by Revenue
3.1.1 Global Top Tumor Early Screening Products Players by Revenue (2017-2022)
3.1.2 Global Tumor Early Screening Products Revenue Market Share by Players (2017-2022)
3.2 Global Tumor Early Screening Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Early Screening Products Revenue
3.4 Global Tumor Early Screening Products Market Concentration Ratio
3.4.1 Global Tumor Early Screening Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Early Screening Products Revenue in 2021
3.5 Tumor Early Screening Products Key Players Head office and Area Served
3.6 Key Players Tumor Early Screening Products Product Solution and Service
3.7 Date of Enter into Tumor Early Screening Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Early Screening Products Breakdown Data by Type
4.1 Global Tumor Early Screening Products Historic Market Size by Type (2017-2022)
4.2 Global Tumor Early Screening Products Forecasted Market Size by Type (2023-2028)
5 Tumor Early Screening Products Breakdown Data by Application
5.1 Global Tumor Early Screening Products Historic Market Size by Application (2017-2022)
5.2 Global Tumor Early Screening Products Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tumor Early Screening Products Market Size (2017-2028)
6.2 North America Tumor Early Screening Products Market Size by Country (2017-2022)
6.3 North America Tumor Early Screening Products Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Tumor Early Screening Products Market Size (2017-2028)
7.2 Europe Tumor Early Screening Products Market Size by Country (2017-2022)
7.3 Europe Tumor Early Screening Products Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Early Screening Products Market Size (2017-2028)
8.2 Asia-Pacific Tumor Early Screening Products Market Size by Country (2017-2022)
8.3 Asia-Pacific Tumor Early Screening Products Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Tumor Early Screening Products Market Size (2017-2028)
9.2 Latin America Tumor Early Screening Products Market Size by Country (2017-2022)
9.3 Latin America Tumor Early Screening Products Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Early Screening Products Market Size (2017-2028)
10.2 Middle East & Africa Tumor Early Screening Products Market Size by Country (2017-2022)
10.3 Middle East & Africa Tumor Early Screening Products Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Exact Sciences
11.1.1 Exact Sciences Company Detail
11.1.2 Exact Sciences Business Overview
11.1.3 Exact Sciences Tumor Early Screening Products Introduction
11.1.4 Exact Sciences Revenue in Tumor Early Screening Products Business (2017-2022)
11.1.5 Exact Sciences Recent Development
11.2 Epigenomics
11.2.1 Epigenomics Company Detail
11.2.2 Epigenomics Business Overview
11.2.3 Epigenomics Tumor Early Screening Products Introduction
11.2.4 Epigenomics Revenue in Tumor Early Screening Products Business (2017-2022)
11.2.5 Epigenomics Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Tumor Early Screening Products Introduction
11.3.4 Abbott Revenue in Tumor Early Screening Products Business (2017-2022)
11.3.5 Abbott Recent Development
11.4 Genomictree
11.4.1 Genomictree Company Detail
11.4.2 Genomictree Business Overview
11.4.3 Genomictree Tumor Early Screening Products Introduction
11.4.4 Genomictree Revenue in Tumor Early Screening Products Business (2017-2022)
11.4.5 Genomictree Recent Development
11.5 Oncognostic GmbH
11.5.1 Oncognostic GmbH Company Detail
11.5.2 Oncognostic GmbH Business Overview
11.5.3 Oncognostic GmbH Tumor Early Screening Products Introduction
11.5.4 Oncognostic GmbH Revenue in Tumor Early Screening Products Business (2017-2022)
11.5.5 Oncognostic GmbH Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Tumor Early Screening Products Introduction
11.6.4 QIAGEN Revenue in Tumor Early Screening Products Business (2017-2022)
11.6.5 QIAGEN Recent Development
11.7 New Horizon Health
11.7.1 New Horizon Health Company Detail
11.7.2 New Horizon Health Business Overview
11.7.3 New Horizon Health Tumor Early Screening Products Introduction
11.7.4 New Horizon Health Revenue in Tumor Early Screening Products Business (2017-2022)
11.7.5 New Horizon Health Recent Development
11.8 iStat Biometical
11.8.1 iStat Biometical Company Detail
11.8.2 iStat Biometical Business Overview
11.8.3 iStat Biometical Tumor Early Screening Products Introduction
11.8.4 iStat Biometical Revenue in Tumor Early Screening Products Business (2017-2022)
11.8.5 iStat Biometical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Tumor Early Screening Products Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Colorectal Cancer
Table 3. Key Players of Liver Cancer
Table 4. Key Players of Cervical Cancer
Table 5. Key Players of Oral Cancer
Table 6. Key Players of Others
Table 7. Global Tumor Early Screening Products Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Tumor Early Screening Products Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Tumor Early Screening Products Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Tumor Early Screening Products Market Share by Region (2017-2022)
Table 11. Global Tumor Early Screening Products Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Tumor Early Screening Products Market Share by Region (2023-2028)
Table 13. Tumor Early Screening Products Market Trends
Table 14. Tumor Early Screening Products Market Drivers
Table 15. Tumor Early Screening Products Market Challenges
Table 16. Tumor Early Screening Products Market Restraints
Table 17. Global Tumor Early Screening Products Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Tumor Early Screening Products Market Share by Players (2017-2022)
Table 19. Global Top Tumor Early Screening Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Early Screening Products as of 2021)
Table 20. Ranking of Global Top Tumor Early Screening Products Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Tumor Early Screening Products Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tumor Early Screening Products Product Solution and Service
Table 24. Date of Enter into Tumor Early Screening Products Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tumor Early Screening Products Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Tumor Early Screening Products Revenue Market Share by Type (2017-2022)
Table 28. Global Tumor Early Screening Products Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Tumor Early Screening Products Revenue Market Share by Type (2023-2028)
Table 30. Global Tumor Early Screening Products Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Tumor Early Screening Products Revenue Market Share by Application (2017-2022)
Table 32. Global Tumor Early Screening Products Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Tumor Early Screening Products Revenue Market Share by Application (2023-2028)
Table 34. North America Tumor Early Screening Products Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Tumor Early Screening Products Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Tumor Early Screening Products Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Tumor Early Screening Products Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Tumor Early Screening Products Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Tumor Early Screening Products Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Tumor Early Screening Products Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Tumor Early Screening Products Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Tumor Early Screening Products Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Tumor Early Screening Products Market Size by Country (2023-2028) & (US$ Million)
Table 44. Exact Sciences Company Detail
Table 45. Exact Sciences Business Overview
Table 46. Exact Sciences Tumor Early Screening Products Product
Table 47. Exact Sciences Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 48. Exact Sciences Recent Development
Table 49. Epigenomics Company Detail
Table 50. Epigenomics Business Overview
Table 51. Epigenomics Tumor Early Screening Products Product
Table 52. Epigenomics Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 53. Epigenomics Recent Development
Table 54. Abbott Company Detail
Table 55. Abbott Business Overview
Table 56. Abbott Tumor Early Screening Products Product
Table 57. Abbott Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 58. Abbott Recent Development
Table 59. Genomictree Company Detail
Table 60. Genomictree Business Overview
Table 61. Genomictree Tumor Early Screening Products Product
Table 62. Genomictree Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 63. Genomictree Recent Development
Table 64. Oncognostic GmbH Company Detail
Table 65. Oncognostic GmbH Business Overview
Table 66. Oncognostic GmbH Tumor Early Screening Products Product
Table 67. Oncognostic GmbH Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 68. Oncognostic GmbH Recent Development
Table 69. QIAGEN Company Detail
Table 70. QIAGEN Business Overview
Table 71. QIAGEN Tumor Early Screening Products Product
Table 72. QIAGEN Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 73. QIAGEN Recent Development
Table 74. New Horizon Health Company Detail
Table 75. New Horizon Health Business Overview
Table 76. New Horizon Health Tumor Early Screening Products Product
Table 77. New Horizon Health Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 78. New Horizon Health Recent Development
Table 79. iStat Biometical Company Detail
Table 80. iStat Biometical Business Overview
Table 81. iStat Biometical Tumor Early Screening Products Product
Table 82. iStat Biometical Revenue in Tumor Early Screening Products Business (2017-2022) & (US$ Million)
Table 83. iStat Biometical Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Tumor Early Screening Products Market Share by Type: 2021 VS 2028
Figure 2. Colorectal Cancer Features
Figure 3. Liver Cancer Features
Figure 4. Cervical Cancer Features
Figure 5. Oral Cancer Features
Figure 6. Others Features
Figure 7. Global Tumor Early Screening Products Market Share by Application in 2021 & 2028
Figure 8. In-hospital Clinic Case Studies
Figure 9. Medical Center Case Studies
Figure 10. Community Case Studies
Figure 11. Family Case Studies
Figure 12. Others Case Studies
Figure 13. Tumor Early Screening Products Report Years Considered
Figure 14. Global Tumor Early Screening Products Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Tumor Early Screening Products Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Tumor Early Screening Products Market Share by Region: 2021 VS 2028
Figure 17. Global Tumor Early Screening Products Market Share by Players in 2021
Figure 18. Global Top Tumor Early Screening Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Early Screening Products as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Tumor Early Screening Products Revenue in 2021
Figure 20. North America Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Tumor Early Screening Products Market Share by Country (2017-2028)
Figure 22. United States Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Tumor Early Screening Products Market Share by Country (2017-2028)
Figure 26. Germany Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Tumor Early Screening Products Market Share by Region (2017-2028)
Figure 34. China Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Tumor Early Screening Products Market Share by Country (2017-2028)
Figure 42. Mexico Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Tumor Early Screening Products Market Share by Country (2017-2028)
Figure 46. Turkey Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Tumor Early Screening Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Exact Sciences Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 49. Epigenomics Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 50. Abbott Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 51. Genomictree Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 52. Oncognostic GmbH Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 53. QIAGEN Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 54. New Horizon Health Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 55. iStat Biometical Revenue Growth Rate in Tumor Early Screening Products Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed